MiNK Therapeutics, Inc. (INKT)
NASDAQ: INKT · Real-Time Price · USD
13.07
+0.26 (2.03%)
At close: Nov 5, 2025, 4:00 PM EST
13.26
+0.19 (1.45%)
After-hours: Nov 5, 2025, 7:21 PM EST

MiNK Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202019
Period Ending
Nov '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019
59283788149-
Upgrade
Market Cap Growth
118.90%-25.23%-58.11%-40.99%--
Upgrade
Enterprise Value
63263164214-
Upgrade
Last Close Price
13.076.9710.7026.1044.60-
Upgrade
PB Ratio
--1.41-2.05-219.746.29-
Upgrade
P/TBV Ratio
----6.29-
Upgrade
Debt / Equity Ratio
-0.22-0.25----0.81
Upgrade
Quick Ratio
0.130.660.301.552.360.21
Upgrade
Current Ratio
0.150.720.321.612.410.29
Upgrade
Return on Equity (ROE)
----239.50%--
Upgrade
Return on Assets (ROA)
-105.19%-137.35%-110.10%-62.69%-51.92%-230.14%
Upgrade
Return on Capital (ROIC)
----165.50%-169.44%-
Upgrade
Earnings Yield
-19.07%-39.05%-60.80%-31.74%-20.22%-
Upgrade
FCF Yield
-12.91%-34.60%-42.87%-21.68%-8.75%-
Upgrade
Buyback Yield / Dilution
-12.62%-9.82%-2.04%-29.38%-7.95%-0.21%
Upgrade
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q